|
2005 Conference Publication Cystatin C to estimate renal function: A meta-analysisRoos, J. F., Doust, J., Tett, S.E. and Kirkpatrick, C. M. J. (2005). Cystatin C to estimate renal function: A meta-analysis. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Journal Article Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitorsBehan, K., Cutts, C. and Tett, S. E. (2005). Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors. European Journal of Clinical Pharmacology, 61 (1), 55-58. doi: 10.1007/s00228-004-0865-6 |
|
2005 Journal Article Pharmacokinetic considerations relating to tacrolimus dosing in the elderlyStaatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001 |
|
2005 Conference Publication Consumers on the map: Australia's QUM mapTett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia. |
|
2005 Conference Publication How much, how often, how long?Tett, S. E. (2005). How much, how often, how long?. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Conference Publication Drug utilisation review across jurisdictions: A reality or still a distant dream?Pulver, L. and Tett, S.E. (2005). Drug utilisation review across jurisdictions: A reality or still a distant dream?. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia. |
|
2005 Journal Article Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C., Duffull, S. B., Morris, R. G. and Tett, S. E. (2005). Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. British Journal of Clinical Pharmacology, 60 (5), 560-565. doi: 10.1111/j.1365-2125.2005.02473.x |
|
2004 Journal Article Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltrationDelDot, Megan E., Lipman, Jeffrey and Tett, Susan E. (2004). Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. British Journal of Clinical Pharmacology, 58 (3), 259-268. doi: 10.1111/j.1365-2125.2004.02143.x |
|
2004 Journal Article Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitionersBajramovic, Jasmina, Emmerton, Lynne and Tett, Susan E. (2004). Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 7 (3), 221-234. doi: 10.1111/j.1369-7625.2004.00280.x |
|
2004 Journal Article Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemiaAtcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011 |
|
2004 Journal Article A pharmacodynamic investigation of tacrolimus in pediatric liver transplantationStaatz, Christine E., Taylor, Paul J., Lynch, Stephen V. and Tett, Susan E. (2004). A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplantation, 10 (4), 506-512. doi: 10.1002/lt.20065 |
|
2004 Conference Publication Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, AustraliaNissen, L. M., Cooke, C., Sketris, I. and Tett, S.E. (2004). Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x |
|
2004 Journal Article Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detectionAtcheson, Bronwyn, Taylor, Paul J., Mudge, David W., Johnson, David W., Pillans, Peter I. and Tett, Susan E. (2004). Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Journal of Chromatography B, 799 (1), 157-163. doi: 10.1016/j.jchromb.2003.10.033 |
|
2004 Conference Publication Sample medication: What do Australian general practitioners think?Nissen, L. M., Hall, K. H. and Tett, S. E. (2004). Sample medication: What do Australian general practitioners think?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication An argument for dose individualisation of sirolimus in renal transplant recipientsDansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x |
|
2004 Journal Article A perspective on Australia's national medicines policyTett, S. E. (2004). A perspective on Australia's national medicines policy. Canadian Journal of Clinical Pharmacology, 11 (1), e28-e38. doi: 10.22374/jptcp.v11i1.62 |
|
2004 Conference Publication How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reportingChan, V. and Tett, S. E. (2004). How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service. |
|
2004 Conference Publication Bayesian population pharmacokinetic analysis of sirolimusDansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University. |
|
2004 Journal Article Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatographyChan, V., Charles, B. G. and Tett, S. E. (2004). Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. Journal of Chromatography B-analytical Technologies In The Biomedical And Life Sciences, 803 (2), 331-335. doi: 10.1016/j.jchromb.2004.01.016 |
|
2004 Journal Article Sampling times for monitoring tacrolimus in stable adult liver transplant recipientsDansirikul, C, Staatz, CE, Duffull, SB, Taylor, PJ, Lynch, SV and Tett, SE (2004). Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Therapeutic Drug Monitoring, 26 (6), 593-599. doi: 10.1097/00007691-200412000-00003 |
